Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1‐tube panel strategy for diagnosis and prognosis of patients with MDS-Reference-Cited by-同舟云学术

Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1‐tube panel strategy for diagnosis and prognosis of patients with MDS

Published:2019-09-09 Issue:3 Volume:98 Page:226-237
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Barreau Sylvain¹²,Green Alexa S.¹,Dussiau Charles¹²,Alary Anne‐Sophie¹²,Raimbault Anna¹²,Mathis Stephanie¹²,Willems Lise³,Bouscary Didier²³,Kosmider Olivier¹²,Bardet Valerie⁴⁵^ORCID,Fontenay Michaela¹²,Chapuis Nicolas¹²^ORCID

Affiliation:

1. Assistance Publique‐Hôpitaux de Paris, Hôpitaux Universitaires Paris CentreService d'Hématologie Biologique Paris France

2. Université de Paris, Institut Cochin, CNRS UMR8104INSERM U1016 Paris France

3. Assistance Publique‐Hôpitaux de ParisHôpitaux Universitaires Paris Centre, Service d'Hématologie Clinique Paris France

4. Assistance Publique‐Hôpitaux de ParisHôpitaux Universitaires Paris Ile de France Ouest, Service d'Hématologie‐Immunologie‐Transfusion Boulogne France

5. INSERM U1173Université Versailles Saint Quentin en Yvelines France

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21843

Reference24 articles.

1. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes

2. The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system

3. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

4. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes

5. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

2. Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms;Leukemia;2024-04-04

3. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms;Clinics in Laboratory Medicine;2023-12

4. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues;Cytometry Part B: Clinical Cytometry;2022-12-20

5. Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood;Frontiers in Immunology;2022-09-14